Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence and risk factors for thromboembolic events in pediatric-onset inflammatory bowel disease: A French population-based study.
Richard N, Leroyer A, Ley D, Dupont C, Bertrand V, Wils P, Gower-Rousseau C, Turck D, Guillon N, Sarter H, Savoye G, Fumery M; “EPIMAD study group”. Richard N, et al. Among authors: savoye g. Dig Liver Dis. 2024 Sep 24:S1590-8658(24)01004-1. doi: 10.1016/j.dld.2024.09.005. Online ahead of print. Dig Liver Dis. 2024. PMID: 39322448 Free article.
Efficacy of ferric carboxymaltose on haemoglobin response among older patients with gastrointestinal bleeding: a randomised clinical trial.
Richard N, Arab-Hocine N, Vannier M, Leblanc-Boubchir R, Pelaquier A, Boruchowicz A, Musikas M, Amil M, Fumery M, Nahon S, Arotcarena R, Gelsi E, Maurin A, Hébuterne X, Savoye G. Richard N, et al. Among authors: savoye g. Age Ageing. 2024 May 1;53(5):afae085. doi: 10.1093/ageing/afae085. Age Ageing. 2024. PMID: 38706390 Clinical Trial.
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID.
Caron B, Seksik P, Buisson A, Wils P, Savoye G, Stefanescu C, Laharie D, Guillo L, Abitbol V, Bonnet J, Altwegg R, Vuitton L, Moussata D, Bourreille A, Biron A, Gilletta C, Fumery M, Nahon S, Nancey S, Camara H, Peyrin-Biroulet L. Caron B, et al. Among authors: savoye g. Therap Adv Gastroenterol. 2024 Aug 7;17:17562848241265776. doi: 10.1177/17562848241265776. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39119370 Free PMC article.
Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based study.
Sarter H, Crétin T, Savoye G, Fumery M, Leroyer A, Dauchet L, Paupard T, Coevoet H, Wils P, Richard N, Turck D, Ley D, Gower-Rousseau C; EPIMAD study Group. Sarter H, et al. Among authors: savoye g. Lancet Reg Health Eur. 2024 Oct 18;47:101097. doi: 10.1016/j.lanepe.2024.101097. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39478988 Free PMC article.
High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn's Disease.
Beaugerie L, Carrat F, Nahon S, Zeitoun JD, Sabaté JM, Peyrin-Biroulet L, Colombel JF, Allez M, Fléjou JF, Kirchgesner J, Svrcek M; Cancers et Surrisque Associé aux Maladies Inflammatoires Intestinales En France Study Group. Beaugerie L, et al. Clin Gastroenterol Hepatol. 2018 Jun;16(6):892-899.e2. doi: 10.1016/j.cgh.2017.11.041. Epub 2017 Dec 2. Clin Gastroenterol Hepatol. 2018. PMID: 29199142
Serum calprotectin as a biomarker for Crohn's disease.
Meuwis MA, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Piver E, Seidel L, Colombel JF, Louis E; GETAID (Groupe d'Étude Thérapeutique Des Affections Inflammatoires Digestives). Meuwis MA, et al. J Crohns Colitis. 2013 Dec;7(12):e678-83. doi: 10.1016/j.crohns.2013.06.008. Epub 2013 Jul 9. J Crohns Colitis. 2013. PMID: 23845231 Clinical Trial.
236 results